H
HCW Biologics Inc. (HCWB)
NCM – Real Time Price. Currency in USD
0.34
+0.03 (10.12%)
At close: May 12, 2026, 4:00 PM EDT
0.34
0.00 (0.00%)
Pre-market: May 13, 2026, 4:43 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.34
+0.03 (10.12%)
At close: May 12, 2026, 4:00 PM EDT
0.34
0.00 (0.00%)
Pre-market: May 13, 2026, 4:43 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.11 | 6.05 | 2.0 | |
| Quick ratio | 0.11 | 5.63 | 2.0 | |
| Debt to Equity | 2.46 | 0.30 | 2.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | -13.40 | -16.91 | 1.0 | |
| Weighted average score | 2.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 7M | 3M | 3M | 54K | 54K |
| Gross Profit | 2M | -575K | -225K | -1M | -1M |
| Operating Income | -15M | -26M | -12M | -13M | -13M |
| Net Income | -15M | -25M | -30M | -22M | -22M |
| EBITDA | -14M | -25M | -11M | -12M | -12M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 78 | 5.5 |
| Next quarter | N/A | 97.05 | 5.5 |
| Current year | 8197.99 | 90.97 | 10 |
| Next year | 3647.78 | 42.71 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 73.07 | 23.9 | 75.3 | -3.56 | 7.8 |
| Y/Y | -93.15 | -2.74 | 68.13 | -13.8 | 3.3 |
| 3y average | -55.08 | -20.69 | -3.71 | 6.04 | 2.0 |
| 5y average | 146.75 | -39.91 | 7.52 | -14.61 | 4.5 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $6.8M significantly exceeds cash reserves ($2.0M), raising financial stability concerns
Total current liabilities $21.1M surpass Total current assets $2.3M, signaling liquidity issues
Debt-to-equity ratio (2.5) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-13.4x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.4M limits the company's ability to reinvest or pay down debt